MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 30.03.2026
Cyclacel Pharmaceuticals ROA 2011-2026 | CYCCP
ROA Jährlich Cyclacel Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -36.63 | -273.86 | -256.16 | -75.57 | -44.35 | -22.95 | -51.15 | -36.77 | -28.73 | -59.97 | -57.91 | -65.97 | -28.58 | -68.13 | -58.63 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -22.95 | -273.86 | -77.69 |
ROA Vierteljährlich Cyclacel Pharmaceuticals
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -87.02 | -114.67 | -123.92 | -157.06 | -153.82 | -140.37 | -75.87 | -92.3 | -72.11 | -39.74 | -50.82 | -45.47 | -43.6 | -28.86 | -34.99 | -30.04 | -24.86 | -15.33 | -27.75 | -34.04 | -39.8 | -36.1 | -46.53 | -44.55 | -42.25 | -26.58 | -33.72 | -30.43 | -29.49 | -21.53 | -36.52 | -44.36 | -51.03 | -45.53 | -56.47 | -52.42 | -50.86 | -44.29 | -60.99 | -66.75 | -69.61 | -49.64 | -63.73 | -61.12 | -40.54 | -18.56 | -28.33 | -24.01 | -46.69 | -43.52 | -56.77 | -60.25 | -55.43 | -44.56 | -13.25 | -13.66 | -17.65 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -13.25 | -157.06 | -51.93 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
ACADIA Pharmaceuticals
ACAD
|
19.07 | $ 22.5 | 1.86 % | $ 3.73 B |  USA |
 |
MorphoSys AG
MOR
|
-20.13 | - | 2.43 % | $ 254 M |  Germany |
 |
Acorda Therapeutics
ACOR
|
-232.99 | - | -24.86 % | $ 820 K | USA |
 |
Adverum Biotechnologies
ADVM
|
-72.8 | - | - | $ 86.2 M | USA |
 |
AlloVir
ALVR
|
-35.68 | - | 4.14 % | $ 49.1 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
6.32 | $ 327.16 | 2.39 % | $ 42.9 B | USA |
 |
Applied Molecular Transport
AMTI
|
-117.57 | - | - | $ 10.1 M | USA |
 |
Amgen
AMGN
|
8.51 | $ 349.22 | 2.71 % | $ 188 B | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
6.02 | $ 20.4 | -0.87 % | $ 954 M | USA |
 |
Applied Therapeutics
APLT
|
-218.41 | - | - | $ 8.42 M | USA |
 |
I-Mab
IMAB
|
7.43 | - | - | $ 866 M |  China |
 |
Aquestive Therapeutics
AQST
|
-52.23 | $ 4.18 | 1.33 % | $ 447 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
23.87 | - | 2.54 % | $ 160 B |  France |
 |
Arcutis Biotherapeutics
ARQT
|
-3.73 | $ 24.57 | 5.59 % | $ 3.13 B | USA |
 |
Biophytis SA
BPTS
|
-89.6 | - | -13.47 % | $ 169 M | France |
 |
AVROBIO
AVRO
|
12.03 | - | 1083.1 % | $ 745 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-489.29 | - | - | $ 7.46 M |  Israel |
 |
AstraZeneca PLC
AZN
|
0.11 | - | - | $ 96.9 B |  Britain |
 |
Midatech Pharma plc
MTP
|
-42.28 | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
-48.81 | $ 1.48 | 8.46 % | $ 394 M | Britain |
 |
BeiGene, Ltd.
BGNE
|
3.5 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Alterity Therapeutics Limited
ATHE
|
-31.06 | $ 3.85 | 2.41 % | $ 9.26 B |  Australia |
 |
BioNTech SE
BNTX
|
65.02 | $ 91.76 | 2.39 % | $ 27.2 B | Germany |
 |
CymaBay Therapeutics
CBAY
|
-24.24 | - | - | $ 3.45 B | USA |
 |
Advaxis
ADXS
|
-289.96 | - | -9.65 % | $ 45.9 M | USA |
 |
Aytu BioScience
AYTU
|
-10.92 | $ 2.71 | 5.51 % | $ 17 M | USA |
 |
Avid Bioservices
CDMO
|
-41.82 | - | - | $ 789 M | USA |
 |
Cidara Therapeutics
CDTX
|
-79.06 | - | - | $ 1.41 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-86.4 | $ 3.06 | 0.99 % | $ 6.66 B | Israel |
 |
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - |  Russia |
 |
Cabaletta Bio
CABA
|
-101.68 | $ 3.06 | -0.33 % | $ 307 M | USA |
 |
Checkpoint Therapeutics
CKPT
|
-752.78 | - | - | $ 169 M | USA |
 |
Cerus Corporation
CERS
|
-7.04 | $ 1.9 | 2.99 % | $ 362 M | USA |
 |
Coherus BioSciences
CHRS
|
65.04 | $ 1.7 | 1.8 % | $ 199 M | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
-88.77 | $ 0.36 | 0.28 % | $ 4.12 M | Israel |
 |
Aeterna Zentaris
AEZS
|
-10.45 | - | 5.93 % | $ 314 M |  Canada |
 |
Checkmate Pharmaceuticals
CMPI
|
-77.89 | - | - | $ 231 M | USA |
 |
AgeX Therapeutics
AGE
|
-275.96 | - | -10.17 % | $ 12.2 K | USA |
 |
Concert Pharmaceuticals
CNCE
|
-48.42 | - | - | $ 401 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-19.95 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-27.57 | - | - | $ 26.5 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
19.41 | $ 25.57 | 2.3 % | $ 3.13 B | USA |
 |
CTI BioPharma Corp.
CTIC
|
-73.85 | - | - | $ 1.2 B | USA |
 |
AIkido Pharma
AIKI
|
-19.87 | - | 1.93 % | $ 17.4 M | USA |
 |
Aptose Biosciences
APTO
|
-254.37 | - | -45.71 % | $ 1.2 M | Canada |
 |
Cellectar Biosciences
CLRB
|
-145.48 | $ 2.81 | 2.18 % | $ 7.33 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
-41.16 | - | - | $ 2.18 B | USA |